What Is the Difference Between AFib and Tachycardia?

Tachycardia is a broad medical term for any heart rate faster than 100 beats per minute, while atrial fibrillation (AFib) is a specific type of abnormal heart rhythm in which the upper chambers of the heart fire electrical signals chaotically. The two overlap: AFib frequently causes tachycardia, which is why people confuse them. But lumping them together obscures real differences in how they feel, why they happen, and what risks they carry. AFib, for instance, is uniquely tied to stroke risk in a way most other fast heart rhythms are not.

Tachycardia Is a Category, Not a Diagnosis

Calling something “tachycardia” is a bit like saying someone has a fever. It describes what is happening (the heart is beating faster than 100 bpm) without telling you why. Your heart rate climbs above 100 every time you exercise, drink too much coffee, run a fever, or get startled. That kind of fast heart rate is sinus tachycardia, and it originates from the heart’s normal pacemaker, the sinus node. Sinus tachycardia can also appear without an obvious trigger: conditions like anemia, infection, pulmonary embolism, hyperthyroidism, and even post-COVID syndrome can push the resting heart rate up, and in some people no clear cause is ever found.¹

Beyond sinus tachycardia, the umbrella also covers supraventricular tachycardias (fast rhythms that originate above the ventricles), ventricular tachycardia (fast rhythms from the lower chambers, which can be life-threatening), and AFib itself. So AFib is actually a subtype of tachycardia in many cases, sitting under the same umbrella. The confusion makes sense: a doctor might tell you “you have tachycardia” as a preliminary observation and later refine it to “you have AFib” once the electrocardiogram reveals the specific pattern. They are not contradicting themselves; they are zooming in.

What Makes AFib a Distinct Rhythm

In a normally beating heart, the two upper chambers (atria) contract in a coordinated squeeze, pushing blood down into the ventricles. In AFib, hundreds of disorganized electrical impulses fire across the atria simultaneously. Instead of a coordinated squeeze, the atria quiver. The result is an “irregularly irregular” heartbeat: the time between one beat and the next changes unpredictably, with no repeating pattern at all. This is the single most distinctive feature of AFib. Other fast heart rhythms tend to be regular, even if they are fast. A person in AFib will often notice that the pulse feels erratic, sometimes with pauses, sometimes with rapid clusters.

AFib also has a self-reinforcing quality. Once the arrhythmia starts, it changes the electrical and structural properties of the atria in ways that make the rhythm more likely to persist and recur, a process researchers call remodeling.² Electrical remodeling, specifically a shortening of the atria’s refractory period, develops within the first few days. But the arrhythmia continues to become more entrenched over weeks and months as structural changes accumulate.³ This is why clinicians describe AFib as progressive: episodes that start out brief and self-terminating (paroxysmal AFib) can eventually become persistent or permanent. Most other forms of tachycardia do not remodel the heart in this particular way.

Why AFib Carries a Unique Stroke Risk

This is the complication that separates AFib from garden-variety fast heart rates. When the atria quiver instead of contracting, blood is not pushed out efficiently. It pools, especially in a small pouch called the left atrial appendage. Pooled blood clots more easily, and if a clot forms and travels to the brain, the result is a stroke. AFib is the cause of roughly one in five acute ischemic strokes.⁴ That is an enormous fraction, and it is the primary reason AFib demands a different treatment approach from other tachycardias.

To gauge an individual’s stroke risk, clinicians use scoring systems that factor in age, sex, heart failure history, high blood pressure, diabetes, and prior stroke or vascular disease. The most widely used is the CHA₂DS₂-VASc score. A recent analysis from a large global registry compared two versions of this score and found their ability to predict stroke was similar.⁵ The practical takeaway for patients: if you have AFib and your score is above a certain threshold, you will almost certainly be prescribed a blood thinner (anticoagulant) to lower stroke risk. People with sinus tachycardia, by contrast, do not face the same clot-forming dynamics and do not need anticoagulation for their heart rhythm.

When a Fast Heart Rate Damages the Heart Muscle

AFib’s stroke risk gets the headlines, but there is a complication that tachycardia of any kind can cause: heart muscle weakening. When the heart beats too fast for too long, the constant overwork can stretch and weaken the ventricles, leading to what is called tachycardia-induced cardiomyopathy. The encouraging part is that this form of heart failure is typically reversible once the fast rhythm is controlled.⁶

AFib can trigger this same cardiomyopathy, as can premature ventricular contractions and other sustained tachyarrhythmias.⁷ The tricky diagnostic puzzle is that a weakened heart can itself cause AFib, and AFib can weaken the heart. Sorting out which came first matters for treatment. If the fast rhythm is the culprit, bringing the rate down or restoring a normal rhythm can allow the heart muscle to recover, sometimes fully.⁸ If the underlying heart disease came first, simply controlling the rhythm will not be enough.

How Symptoms Overlap and Where They Diverge

Both AFib and other forms of tachycardia share a core set of symptoms: palpitations, a fluttering or pounding sensation in the chest, shortness of breath, lightheadedness, and fatigue. Many people cannot tell the difference based on symptoms alone, and some people with AFib have no symptoms at all, discovering their arrhythmia only when a doctor checks their pulse or runs an ECG.

A few clues lean toward AFib specifically. The feeling of an irregular, unpredictable heartbeat is more characteristic of AFib than of sinus tachycardia or most supraventricular tachycardias, which tend to feel fast but steady. AFib episodes can last minutes, hours, or days, while some other fast rhythms come and go in bursts of seconds to minutes. Exercise intolerance that seems out of proportion to your fitness level is another common AFib complaint, because the atria are not contributing their usual “kick” to fill the ventricles, reducing how much blood the heart pumps with each beat.

None of these are reliable enough to diagnose AFib by feel. The gold standard is an electrocardiogram, which shows the absence of organized P waves (the electrical blip that represents a coordinated atrial contraction) and irregular intervals between the main QRS complexes. In sinus tachycardia, those P waves are present and normal looking; the heart is simply beating faster.

Treatment Strategies Are Fundamentally Different

For sinus tachycardia, the treatment is almost always to address whatever is causing the fast rate. If you are dehydrated, you get fluids. If you have an infection, you treat the infection. If your thyroid is overactive, you treat the thyroid. The fast heart rate is a symptom, not the primary problem. Medications to slow the heart are rarely needed and can even be counterproductive if the tachycardia is a helpful compensatory response, for example during severe bleeding.

AFib treatment has two distinct layers. The first is preventing stroke with anticoagulants, as described above. The second is managing the rhythm itself, and here clinicians face a genuine strategic choice between two approaches: rate control (accepting that the heart is in AFib but using medications to keep the ventricular rate from running too fast) and rhythm control (actively trying to restore and maintain a normal sinus rhythm using drugs, electrical cardioversion, or catheter ablation).

This debate has evolved over the past two decades. An early landmark trial found that rhythm control offered no survival advantage over rate control and was actually associated with more hospitalizations and drug side effects.⁹ That result surprised many cardiologists, and for years rate control was considered the pragmatic default for many patients. More recent evidence, however, has shifted the picture. A meta-analysis of randomized trials found that a rhythm control strategy reduced cardiovascular death by about a fifth and also lowered the risk of stroke and heart failure hospitalization, though it did not significantly reduce death from all causes.¹⁰ The improvement was driven largely by newer studies that made greater use of catheter ablation, suggesting that the tools available for rhythm control have gotten better since the earlier trials.

The practical upshot: today, rhythm control is increasingly favored for patients diagnosed early, patients with significant symptoms, and those with heart failure. Rate control remains a reasonable option for older patients who tolerate AFib well and whose stroke risk is managed with anticoagulants. No equivalent debate exists for sinus tachycardia, because nobody is trying to “control the rhythm” of a heart that is already in normal rhythm.

Risk Factors for AFib Versus Ordinary Fast Heart Rates

Sinus tachycardia is most commonly a response to something: exercise, stress, dehydration, caffeine, fever, pain. When it becomes chronic without an obvious reason, clinicians look for thyroid disease, anemia, pulmonary problems, or conditions like postural tachycardia syndrome.¹ In younger people, anxiety and deconditioning are common contributors.

AFib has a partly overlapping but distinct risk profile. Age is the strongest predictor: the majority of AFib cases occur in people over 65. High blood pressure, obesity, diabetes, obstructive sleep apnea, and heart failure all raise the risk. Alcohol plays a notable role. The mechanisms linking alcohol to AFib include direct toxicity to heart tissue, its contribution to obesity, worsening of sleep-disordered breathing, and elevation of blood pressure.¹¹ Even moderate drinking has been associated with increased AFib risk, which surprises many people who assume alcohol-related heart problems only appear with heavy consumption.

Endurance athletes present an interesting paradox: they tend to have low resting heart rates (the opposite of tachycardia) yet are at higher risk for AFib than the general population. Years of intense training can enlarge the atria, increase vagal tone, and create the structural substrate for AFib. This is one situation where being fit does not protect you from a specific arrhythmia.

Detecting AFib with Smartwatches

Consumer wearables have added a new dimension to the tachycardia-versus-AFib question. Smartwatches can flag an irregular rhythm by measuring your pulse pattern through optical sensors and, on some models, by recording a single-lead ECG from your wrist. A systematic review and meta-analysis of the Apple Watch’s ECG feature found pooled sensitivity of about 95% and specificity of about 95% for detecting AFib.¹² Those numbers are impressive for a consumer device, but they come with caveats. A 95% specificity means that about 5% of people flagged may not actually have AFib. In a population where AFib is uncommon (say, healthy adults under 40), even a good test produces a lot of false alarms relative to true catches.

What wearables do well is catch episodic AFib that might otherwise slip through. Because the arrhythmia can come and go, a standard ECG in a doctor’s office captures only a few seconds of your rhythm and may miss it entirely. A watch monitoring your pulse around the clock has a much larger window. If your watch alerts you to an irregular rhythm, the right next step is to get a confirmed reading from a medical-grade device, not to panic or to ignore it.

AFib in Children and Young Adults

AFib is overwhelmingly a condition of older adults. When children show up in an emergency room with a fast heart rate, the diagnosis is almost always a different supraventricular tachycardia, not AFib. That said, AFib in children does occur, and when it does it is easy to miss. A case report described a healthy nine-year-old boy who arrived with chest pain and palpitations and was initially thought to have a typical supraventricular tachycardia. It was only after adenosine was given, which briefly interrupted the electrical circuit and revealed the underlying chaotic atrial activity, that the true diagnosis of AFib emerged.¹³ Most reported pediatric AFib cases involve children with structural heart defects or other underlying conditions, making isolated AFib in an otherwise healthy child a rarity worth noting because of how easily it can be overlooked.

In young adults, the picture is somewhat different. AFib occasionally surfaces in people in their twenties and thirties, sometimes triggered by binge drinking (colloquially called “holiday heart”), sometimes by stimulant use, and sometimes with no clear explanation. The prognosis in younger patients tends to be better because they are less likely to have the coexisting conditions that make AFib more dangerous, but the arrhythmia still warrants evaluation and, depending on stroke risk factors, possible anticoagulation. The key point is that age should not be the sole reason to dismiss the possibility: a young person with an irregular pulse deserves the same ECG workup as an older one.

When to Worry About a Fast Heart Rate

Not every episode of tachycardia signals a problem. Your heart rate rises with exercise, caffeine, dehydration, and emotional stress, and it should. A resting heart rate that occasionally hits 100–110 after a strong cup of coffee is not the same as waking up at 2 a.m. with your heart pounding at 150 for no reason. Context matters enormously.

Situations that warrant prompt medical attention include a fast heart rate accompanied by chest pain, severe shortness of breath, or fainting. A heart rate above 150 at rest that does not come down within a few minutes is worth evaluating urgently, regardless of whether the underlying rhythm turns out to be AFib or another arrhythmia. An irregular pulse that you can feel at the wrist, particularly one with no predictable pattern, is a reason to get an ECG sooner rather than later, because it suggests AFib until proven otherwise. And if you have already been diagnosed with AFib and your rate suddenly climbs despite being on medication, that is a sign your treatment plan may need adjustment.

One underappreciated point: some people experience both AFib and other types of tachycardia at different times. Having one arrhythmia does not immunize you against another. If your symptoms change in character, such as going from a steady fast pounding to an erratic flutter, or vice versa, mention it to your doctor, even if you already have a diagnosis on file. The management of each arrhythmia can be quite different, and getting the right label matters for getting the right treatment.